AK MEDICAL (01789) · Company profile · Eqvero

AK MEDICAL

01789HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.48 bn CNY	1.35 bn CNY	1.09 bn CNY	1.05 bn CNY	761.44 m CNY
Cost of revenue	478.16 m CNY	441.85 m CNY	328.44 m CNY	335.21 m CNY	188.09 m CNY
Research and development expense	141.64 m CNY	144.77 m CNY	142.62 m CNY	110.87 m CNY	113.07 m CNY
Selling, general and administrative expense	417.58 m CNY	384.86 m CNY	352.25 m CNY	298.42 m CNY	292.66 m CNY
Operating profit after depreciation	373.88 m CNY	300.78 m CNY	211.48 m CNY	238.34 m CNY	99.44 m CNY
Operating profit before depreciation	480.76 m CNY	397.12 m CNY	302.42 m CNY	318.74 m CNY	173.59 m CNY
EBIT	373.88 m CNY	300.78 m CNY	211.48 m CNY	238.34 m CNY	99.44 m CNY
EBITDA	480.76 m CNY	397.12 m CNY	302.42 m CNY	318.74 m CNY	173.59 m CNY
Interest expense	3.57 m CNY	923 k CNY	1.29 m CNY	2.17 m CNY	1.61 m CNY
Profit before tax	394.98 m CNY	319.82 m CNY	231.12 m CNY	240.29 m CNY	108.56 m CNY
Income tax expense	55.89 m CNY	45.9 m CNY	49.01 m CNY	35.52 m CNY	15.94 m CNY
Income before extraordinary items	339.09 m CNY	273.93 m CNY	182.1 m CNY	204.77 m CNY	92.62 m CNY
Common dividends	118.6 m CNY	75 m CNY	45.75 m CNY	59.8 m CNY	22.81 m CNY
Total dividends	118.6 m CNY	75 m CNY	45.75 m CNY	59.8 m CNY	22.81 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.